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The primary function of the epidermis is to produce
the protective, semi-permeable stratum corneum that
permits terrestrial life. The barrier function of the stra-
tum corneum is provided by patterned lipid lamellae
localized to the extracellular spaces between corneo-
cytes. Anucleate corneocytes contain keratin ¢laments
bound to a peripheral corni¢ed envelope composed of
cross-linked proteins. The many layers of these specia-
lized cells in the stratum corneum provide a tough and
resilient framework for the intercellular lipid lamellae.
The lamellae are derived from disk-like lipid mem-
branes extruded from lamellar granules into the inter-
cellular spaces of the upper granular layer. Lysosomal
and other enzymes present in the extracellular com-
partment are responsible for the lipid remodeling re-
quired to generate the barrier lamellae as well as for
the reactions that result in desquamation. Lamellar
granules likely originate from the Golgi apparatus and
are currently thought to be elements of the tubulo-vesi-
cular trans-Golgi network. The regulation of barrier li-
pid synthesis has been studied in a variety of models,
with induction of several enzymes demonstrated during
fetal development and keratinocyte di¡erentiation, but
an understanding of this process at the molecular gene-
tic level awaits further study. Certain genetic defects in
lipid metabolism or in the protein components of the
stratum corneum produce scaly or ichthyotic skin with
abnormal barrier lipid structure and function. The in-
£ammatory skin diseases psoriasis and atopic dermatitis
also show decreased barrier function, but the underly-
ing mechanisms remain under investigation. Topically
applied ‘‘moisturizers’’ work by acting as humectants
or by providing an arti¢cial barrier to trans-epidermal
water loss; current work has focused on developing a
more physiologic mix of lipids for topical application
to skin. Recent studies in genetically engineered mice
have suggested an unexpected role for tight junctions
in epidermal barrier function and further developments
in this area are expected. Ultimately, more sophisticated
understanding of epidermal barrier function will lead
to more rational therapy of a host of skin conditions in
which the barrier is impaired. Key words: ceramides/
desquamation/Golgi/keratinocyte/lipid. J Invest Dermatol
121:231 ^241, 2003
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ife on dry land requires the presence of a barrier to
water loss to prevent desiccation (Attenborough, 1980).
That the skin provided this barrier was intuitively
obvious, but it was not until the 1940s that the stratum
corneum (SC) clearly emerged as the speci¢c site
of this barrier (Winsor and Burch, 1944; Blank, 1953). Although
the typical ‘‘basket-weave’’ appearance of the SC in routine histo-
logic sections does not give the impression that it could function
as an e¡ective barrier, this is an artifact of tissue processing. In
fact, as can be seen on frozen sections of the epidermis and
in fortuitous electron microscopic sections (Fig 1), the corneo-
cytes are tightly opposed to each other. The barrier to water
permeation is not absolute and the normal movement of water
through the SC into the atmosphere is known as transepidermal
water loss (TEWL) and constitutes part of insensible water
loss. The SC is also the principal barrier to the percutaneous
penetration of exogenous substances, both accidentally encoun-
tered as well as deliberately applied. Epidermal barrier function
and the related ¢eld of percutaneous absorption have been active
areas of investigation in both academia and industry for many
years; the information presented in this review is focused on the
water barrier function of the epidermis and is intended as an
overview, highlighting key points with relevance to both clini-
cians and basic scientists.
LIPIDS COMPRISE THE PERMEABILITY BARRIER
In the 1950s and 1960s, experiments were done showing that sol-
vent extraction of epidermis dramatically increased water perme-
ability, implicating lipids in cutaneous barrier function (Berenson
and Burch, 1951; Onken and Moyer, 1963; Matoltsy et al, 1968;
Scheuplein and Ross, 1970; Sweeny and Downing, 1970). Although
some earlier studies had noted the pronounced changes in lipid
composition that accompany keratinocyte di¡erentiation, it was
not until the pioneering studies of Gray, Yardley, and colleagues
in the 1970s that an accurate picture of epidermal and SC lipid
composition was established (reviewed in Yardley and Summerly,
1981). Thin layer chromatographic analysis of the solvent extracta-
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ble lipids from SC reveals an unusual lipid composition consisting
of a roughly equimolar mixture of ceramides (45^50% by weight),
cholesterol (25%), and free fatty acids (10^15%) plus less than 5%
each of several other lipids, the most important of which is choles-
terol sulfate. The detailed structures of the ceramide species of pig,
mouse, and human skin were determined in the 1980s (Wertz and
Downing, 1983; Long et al, 1985; Madison et al, 1990) with re¢ne-
ments still being published (Robson et al, 1994; Doering et al,
1999a; Stewart and Downing, 1999; Hamanaka et al, 2002;
Ponec et al, 2003). Human SC ceramide structures are shown in
Fig 2.
STRATUM CORNEUM LIPIDS ARE ORGANIZEDAS
STACKED MEMBRANE SHEETS IN THE
INTERCELLULAR SPACES
Early freeze fracture electron micrographic studies of the epider-
mis had demonstrated the presence of broad continuous lipid
sheets in the extracellular spaces of the SC (Breathnach et al, 1973;
Elias and Friend, 1975; Elias et al, 1977), but these lipid membranes
were not visible in conventional electron microscopy. Fixation
with ruthenium tetroxide, however, which is more reactive
than the usual osmium tetroxide ¢xative, clearly demonstrates
the stacked and patterned lipid sheets in the extracellular spaces
of the SC (Madison et al, 1987; Fig 3). All of the free fatty acids
and the amide-linked fatty acid chains in the ceramides are non-
branched and have no double bonds. This allows for tight lateral
packing and the formation of highly ordered gel phase membrane
domains, which are less £uid and less permeable than typical li-
quid crystalline phospholipid-dominant biologic membranes.
Cholesterol may provide some necessary £uidity to the mem-
branes, which might otherwise be too rigid and possibly brittle.
Numerous biophysical studies of SC structure suggest the pre-
sence of coexisting liquid crystalline and gel phase domains in
the membranes of the SC.This concept was suggested by Forslind
(1994) and presented as the ‘‘domain mosaic’’model; recently a new
model for the existence of £uid phases within the lamellae, the
‘‘sandwich model’’, was presented by Bouwstra et al (2000). Norlen
(2001b), however, has very recently proposed a di¡erent ‘‘single gel
phase’’model that he feels is more consistent with the documented
barrier properties of the SC. There are still many unanswered
questions about the exact way in which the SC lipids are orga-
nized at the molecular level and this is an active area of research
(reviewed in Bouwstra et al, 2003). Understanding the physical
structure of the membranes is critical to understanding their func-
tion as a barrier, both to water and to other substances, and ulti-
mately to understanding the mechanisms of barrier disruption in
a variety of skin diseases.
Figure1. Electron micrograph showing the upper stratum granulo-
sum and SC of an organotypic mouse keratinocyte culture.This ¢g-
ure shows a portion of a micrograph previously published in Madison et al
(1988). Arrows, keratohyalin granules; arrowheads, intercellular spaces be-
tween closely opposed corneocytes; stars, artifactual separation. The inter-
cellular spaces appear empty in this osmium tetroxide post¢xed specimen.
Original magni¢cation 6000.
Figure 2. Structures of the free ceramides of human SC. Numbers 1
to 8 represent thin layer chromatographic mobility with ceramide 1 being
the least polar and ceramide 8 the most polar. Ceramide 9 (EOP) has re-
cently been discovered (Ponec et al, 2003) and has a thin layer chromato-
graphic mobility between that of ceramide 2 and ceramide 3. The letters
in parentheses give the ceramide classi¢cation as suggested in Motta et al
(1993).
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STRATUM CORNEUM BARRIER LIPIDS ORIGINATE
FROM LAMELLARGRANULES
Lamellar granules (LG) are small organelles with a bounding
membrane, most prominent in the granular cell layer of the epi-
dermis and visible only by electron microscopy. They contain
stacks of lipid lamellae (Fig 4a) composed of phospholipids, cho-
lesterol, and glucosylceramides (Freinkel and Traczyk, 1985) that
are the precursors of the SC intercellular lipids (reviewed in
Landmann, 1988). Late in epidermal di¡erentiation, at the transi-
tion from granular cell to corneocyte, LG are thought to fuse
with the plasma membrane of the granular cell and discharge
their lipid membranes into the intercellular space (Fig 4b). Along
with the lipids, LG secrete a group of acid hydrolases (Freinkel
and Traczyk, 1985; Grayson et al, 1985; Menon et al, 1986, 1992),
which break down the phospholipids and convert glucosylcera-
mides to ceramides. The enzyme responsible for the latter reac-
tion (Holleran et al, 1994), b-glucocerebrosidase, is the enzyme
defective in Gaucher disease. Although in most Gaucher patients
residual enzyme activity is su⁄cient to catalyze the cutaneous re-
action, there is a subset of patients with severe enzyme de¢ciency
who present as collodion babies, have abnormal barrier function,
and die in the neonatal period (Sidransky et al, 1992).
Other enzymes involved in the lipid metabolic changes that
occur after extrusion of LG contents include acid sphingomyeli-
nase and secretory phospholipase A2, both of which have been
shown to be required for permeability barrier function (Jensen
et al, 1999; Elias et al, 2000; Schmuth et al, 2000). Lysosomal acid
lipase activity is also present in LG (Madison et al, 1998), but its
exact function has not been determined. Some of the proteases
that appear to regulate desmosome breakdown and contribute to
desquamation (see below) may also be delivered via LG (Sondell
et al, 1995).
Concurrent with the complex changes in lipid composition
that occur following extrusion of LG contents, the short stacks
of membranes reorganize structurally to form patterned lamellar
sheets as shown in Fig 3. This transformation has been suggested
to occur via edge-to-edge fusion of the lipid stacks (Landmann,
1986) and calcium may promote this process (Abraham et al, 1987).
Based on knowledge of the lipid composition of the lamellae and
their electron microscopic appearance in ruthenium tetroxide-
¢xed sections, a model for their biochemical structure has been
proposed (Swartzendruber et al, 1989).
LIPIDS UNIQUE TO KERATINIZING EPITHELIA MAY
PLAYA SPECIFIC ROLE IN MEMBRANE FORMATION
LG are particularly enriched in a lipid unique to keratinizing
epithelia, acylglucosylceramide (AcylGlcCer). This unusual lipid
has a very long chain o-hydroxy fatty acid moiety (C28^36) with
linoleic acid (an essential fatty acid) ester-linked to the o-hydro-
xyl group (Abraham et al, 1985; Fig 5, top). The interior lipid la-
mellae of LG have been suggested to arise from the £attening and
stacking of lipid vesicles (Landmann, 1986) and AcylGlcCer has
been proposed to function as a molecular rivet to accomplish this
process (Wertz and Downing, 1982; Fig 5, bottom).The fatty acid
chain is long enough to span completely a lipid bilayer and allow
the linoleate tail to insert into a lea£et of a neighboring bilayer as
shown in Fig 5 (bottom). Figure 4(a, right) schematically shows
the interior structure of a LG as £attened and stacked lipid vesi-
cles. Evidence to support this model includes the ability of
AcylGlcCer to cause the £attening and aggregation of lipid lipo-
somes in vitro (Landmann et al, 1984). Menon et al (1992) have
suggested an alternative model of accordion-like pleating of lipid
membranes to explain the appearance of LG contents followed by
‘‘unfurling’’ after extrusion. AcylGlcCer could function as a rivet
in this model as well. As the biophysics of membrane dynamics
and the function of the Golgi apparatus (see below) are better un-
derstood, new models of LG assembly/extrusion may well
emerge. After extrusion of LG contents, AcylGlcCer is deglyco-
sylated, along with the rest of the glucosylceramides, to produce
acylceramide (Fig 6, middle structure). Acylceramide is thought
to perform the same molecular rivet role in the SC lamellae as
AcylGlcCer does in the LG, and there are X-ray di¡raction data
to support this concept (Schreiner et al, 2000).
Acylceramide and its precursor are the two principal carriers of
linoleic acid in the SC and living epidermis, respectively. It has
been known for years that essential fatty acid de¢ciency results
in poor cutaneous barrier function and increased TEWL (re-
viewed inWertz et al, 1987). These e¡ects correlate with replace-
ment of linoleic acid by oleic acid in AcylGlcCer and
acylceramide (Melton et al, 1987), a substitution that results in al-
Figure 3. Electron micrograph showing the stacked and patterned
lamellar membrane sheets in a single intercellular space in mouse
SC post¢xed with ruthenium tetroxide.The corni¢ed envelope of the
lower corneocyte is clearly visible (arrows); ICS, intercellular space; K, ker-
atin contents of the corneocytes bordering the intercellular space. Original
magni¢cation  200,000.
Figure 4. (a) Left: electron micrograph of a single LG in mouse
epidermis. A lower magni¢cation view of the same LG was used in a pre-
viously published ¢gure (Madison et al, 1987). Arrows, bounding mem-
brane. Original magni¢cation  300,000. Right: a schematic diagram of a
LG as suggested by Landmann (1986). (b) Electron micrograph of extruded
LG contents in the intercellular space at the junction of the granular layer
and the SC. G, granular cell; ICS, intercellular space; Arrows, granular cell
plasma membrane; open arrow, LG. Original magni¢cation 125,000.
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tered biophysical properties of the SC lamellae (Bouwstra et al,
2002) and increased water permeability.
THE LIPID ENVELOPE
Each corneocyte has an approximately 10 nm thick tough periph-
eral protein envelope, called the corni¢ed envelope, that is com-
posed of several structural proteins, notably involucrin and
loricrin, cross-linked by sulfhydryl oxidases and transglutami-
nases (reviewed in Kalinin et al, 2002). The interior surface of the
corni¢ed envelope is linked to the bundles of keratin ¢laments
that ¢ll the intracellular compartment of corneocytes. The multi-
ple layers of corneocytes in the SC contribute a tough and resili-
ent framework for the intercellular lipid lamellae. On the exterior
(extracellular) surface of the corni¢ed envelope is a covalently
bound layer of very long chain o-hydroxyceramides called the
lipid envelope (Swartzendruber et al, 1987; Wertz and Downing,
1987; Fig 6, bottom). This structure can be seen on electron mi-
croscopy of SC that has been solvent extracted to remove all of
the free lipid, as shown in Fig 7. Evidence suggests that the o-
hydroxyceramides are ester-linked to involucrin amino acid resi-
dues (Downing, 1992; Marekov and Steinert, 1998) and transglu-
taminase has been shown to be capable of catalyzing this reaction
(Nemes et al, 1999). Speci¢c three-dimensional conformations for
involucrin that would allow for attachment of lipids on the exter-
ior surface and other envelope proteins on the interior surface of
the corni¢ed envelope have been proposed (Lazo and Downing,
1999; Kajava, 2000). Surprisingly, however, both involucrin
(Djian et al, 2000) and loricrin (Koch et al, 2000; Jarnik et al, 2002)
knockout mice have relatively normal-appearing corni¢ed envel-
opes and no epidermal phenotype, suggesting great redundancy
in the components of the epidermal barrier (Steinert, 2000). This
also implies that other envelope proteins are able to bond with o-
hydroxyceramides and, indeed, new envelope-associated proteins
continue to be discovered (Cabral et al, 2001; Marshall et al, 2001).
AcylGlcCer, the precursor of acylceramide (see above), is also
the precursor of the o-hydroxyceramides of the lipid envelope.
Wertz (1996) has found that two-thirds of LG AcylGlcCer is in
the bounding membrane; this suggests that lipid envelope o-hy-
droxyceramides are delivered to the cell surface when LG bound-
ing membranes fuse with the granular cell plasma membrane
(Wertz, 1996; Kalinin et al, 2002). Recent evidence suggests that
most or all or the o-hydroxyceramides are bound by their o-hy-
droxyl ends (Nemes et al, 1999; Doering et al, 1999b; Stewart and
Downing, 2001). This implies that the linoleic acid tail must be
removed from the o-hydroxyl end of AcylGlcCer; the enzyme
responsible for this deacylation is not known, but candidates in-
clude transglutaminase (Nemes et al, 1999; Kalinin et al, 2002) and
acid lipase.1 The uniquely long fatty acid chains of the lipid en-
velope ceramides span the distance of a typical plasma membrane
bilayer leaving the sphingosine chains free to interdigitate with
the nonbound intercellular lipid lamellae. This chain interdigita-
tion may contribute to the patterned organization of the lamellae
seen on electron microscopy. The structures of the very long
chain o-hydroxy fatty acid-containing ceramides are shown in
Fig 6. Note that human ceramide 4 and the newly discovered cer-
amide 9 (Fig 2) also contain a very long chain o-hydroxy fatty
acid and contribute o-hydroxyceramides to the lipid envelope.
Di¡erentiation-related changes in lipid structures are illustrated
schematically in Fig 8.
DESQUAMATION
It has long been known from the clinical example of X-linked
ichthyosis, caused by cholesterol sulfatase de¢ciency (Shapiro
et al, 1978), that the hydrolysis of cholesterol sulfate in the SC is
important for corneocyte desquamation. The mechanism by
which excess cholesterol sulfate inhibits desquamation and its hy-
drolysis promotes desquamation, however, is still under investi-
gation. Excess cholesterol sulfate has been suggested to alter the
structure and function of the lipid bilayers (Zettersten et al, 1998;
Figure 5. Top: structure of acylglucosylceramide. Bottom: proposed
model of acylglucosylceramide function in the £attening and stacking of
lipid vesicles to generate the double bilayer structure of the internal LG
lamellae. The orientation of acylglucosylceramide is not known and both
possibilities are shown. The vesicle and double bilayer disk are shown in
cross-section. Arrowheads, linoleate moiety; Glu, glucose.
Figure 6. The very long chain x-hydroxy fatty acid-containing cer-
amides of mammalian epidermis. LG acylglucosylceramides are the
precursors of the acylceramides (ceramide 1 (EOS) is shown) in the SC in-
tercellular lamellae and the o-hydroxyceramides of the lipid envelope. See
text for details.
Figure 7. Electron micrograph of mouse SC that has been solvent
extracted to remove all of the free lipid. A lucent band (the lipid en-
velope) remains on the exterior surface of the corni¢ed envelopes of adja-
cent corneocytes. In solvent-extracted SC the lipid envelopes are tightly
opposed and a narrow dark line can be seen where they join (seeWertz et
al, 1989 for a more detailed discussion). The dominant component of the
lucent band is very long chain o-hydroxyceramides derived from LG acyl-
glucosylceramides (likely from the LG bounding membrane; see text and
Fig 6) and covalently bound to corni¢ed envelope proteins. K, keratin con-
tents of two adjacent corneocytes; arrowheads, corni¢ed envelopes. Ruthe-
nium tetroxide post¢xation, original magni¢cation 125,000.
1Sando GN, Howard EJ, Madison KC: Acid lipase expression in cultured
human keratinocytes: Potential role in epidermal ceramide metabolism.
J Invest Dermatol 108:554a, 1997 (Abstr.)
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Bouwstra et al, 1999). Proteases, especially SC tryptic enzyme and
SC chymotryptic enzyme, have been implicated in desmosome
breakdown and corneocyte desquamation (Hansson et al, 1994;
Horikoshi et al, 1998; Brattsand and Egelrud, 1999; Simon et al,
2001), and cholesterol sulfate has been shown to inhibit some of
their activities (Sato et al, 1998). A recent study showed that cho-
lesterol sulfate inhibits transglutaminase-mediated involucrin
cross-linking as well as involucrin esteri¢cation to the o-hydro-
xyceramides of the lipid envelope (Nemes et al, 2000). Any of
these mechanisms could contribute to the so-called ‘‘retention hy-
perkeratosis’’ of X-linked ichthyosis.
REGULATION OF EPIDERMAL LIPID SYNTHESIS
Epidermal barrier lipid synthesis has been studied in vivo in adult
pigs (Hedberg et al, 1988;Wertz and Downing, 1990) and hairless
mice (reviewed in Feingold and Elias, 2000), in fetal rat develop-
ment models in vivo and in vitro (reviewed inWilliams et al, 1998),
during fetal mouse development (Doering et al, 2002), and in a
variety of keratinocyte culture models (Madison et al, 1989, 1990;
Jetten et al, 1992; Sando et al, 1996; Ponec et al, 1997;Watanabe et al,
1998).We know from in vivo metabolic labeling studies that bar-
rier lipids are largely synthesized de novo from acetate (Hedberg
et al, 1988; Wertz and Downing, 1990). The loss of phospholipids
and the conversion of glucosylceramides to ceramides and
AcylGlcCer to acylceramide and o-hydroxyceramides during
epidermal di¡erentiation have been demonstrated in vivo as well
as in vitro (Hedberg et al, 1988; Madison et al, 1990). As an essential
fatty acid, linoleate must be derived from the circulation, but
may also be recycled within the epidermis (Madison et al, 1989;
Wertz and Downing, 1990).
Several of the enzymes known to be required for either barrier
lipid synthesis or postextrusion processing are induced during
keratinocyte di¡erentiation in vitro (Jetten et al, 1992; Sando et al,
1996;Watanabe et al, 1998) or during fetal rat epidermal develop-
ment (Williams et al, 1998). Submerged explant cultures of fetal
rat skin recapitulate in utero barrier development and the develop-
ment of the barrier can be inhibited by testosterone and stimu-
lated by exogenous application of glucocorticoids, thyroid
hormone, and estrogen and by lifting the cultures to the air^li-
quid interface (Williams et al, 1998). More recently, peroxisome
proliferator activated receptor (PPARa) ligands (clo¢brate, lino-
leic acid, oleic acid) and farnesol, a metabolite in the cholesterol
biosynthetic pathway, have been shown to stimulate epidermal
di¡erentiation and barrier development in fetal rats both in utero
and in skin explant cultures (Hanley et al, 1999). PPAR are nuclear
hormone receptors that heterodimerize with retinoid X receptors
to regulate the transcription of several genes involved in lipid me-
tabolism and have been most studied in adipocytes. Recently,
mice transgenic for a dominant-negative mutant retinoic acid
receptor a were shown to have markedly decreased barrier func-
tion associated with abnormal lipid processing, implicating reti-
noid receptor-mediated signaling pathways in barrier formation
(Attar et al, 1997).Which genes involved in epidermal barrier lipid
synthesis or processing might be regulated by these hormones
and receptors is not known, although increased b-glucocerebro-
sidase and cholesterol sulfatase activity following treatment with
PPAR ligands has been shown (Hanley et al, 1999). PPAR-a
knockout mice show a delay in fetal SC formation as well as
decreased b-glucocerebrosidase activity, but are normal by the
time of birth (Schmuth et al, 2002). Another study in transgenic
mice has demonstrated that a member of the kruppel family of
transcription factors, Klf4, is essential for normal barrier develop-
ment (Segre et al, 1999). These and other mouse models should be
of great help in dissecting the mechanisms of barrier formation at
the molecular genetic level.
Arti¢cial barrier disruption of hairless mouse skin by acetone
wiping or tape stripping (as measured by increased TEWL) has
been used as a model to study the events involved in barrier
repair. The most commonly used approach to determine if an
e¡ect is mediated by loss of barrier rather than a nonspeci¢c
injury e¡ect is to immediately cover one site with a vapor
impermeable membrane and compare the response to an uncov-
ered site. Studies using this model have shown acute barrier dis-
ruption to stimulate epidermal proliferation and increase mRNA
levels and activities of several (but not all) of the enzymes in-
volved in barrier lipid synthesis, in particular those associated
with fatty acid, cholesterol, and ceramide synthesis (Feingold
and Elias, 2000). In general, vapor-impermeable and semiperme-
able membranes inhibit the stimulatory response and delay bar-
rier repair, the degree of inhibition correlating with the degree
of impermeability. The molecular mechanisms by which barrier
disruption produces, and arti¢cial barrier restoration inhibits,
these e¡ects remain unknown, although changes in SC water
content (Denda et al, 1998; Fluhr et al, 1999), ion content and dis-
tribution (particularly calcium) (Lee et al, 1998), or cytokine pro-
duction (Jensen et al, 1999) may be involved in the signaling
pathways.
Although a recent study showed an increase in serine
palmitoyltransferase (the rate-limiting enzyme in sphingolipid
synthesis) mRNA following tape stripping of human skin
(Stachowitz et al, 2002), as rodent epidermis is di¡erent from
human, including having poorer barrier function, which of
the ¢ndings in hairless mouse models will translate to human
skin needs further study (Rigg and Barry, 1990, and references
therein). Several studies of human skin in vivo have shown no ef-
fect of occlusion with membranes of varying permeability
on barrier recovery following tape stripping, detergent-induced
damage, or wounding (Silverman et al, 1989; Van de Kerkhof
et al, 1995;Welzel et al, 1995, 1996; Fluhr et al, 1999) and a study in
premature infants showed that the use of semipermeable mem-
branes improved barrier function in treated compared with un-
treated sites (Mancini et al, 1994). Under physiologic conditions,
barrier lipid synthesis, LG formation, and lipid extrusion take
place continuously under a competent barrier. Whether barrier
abrogation results in additional stimulation of all of these pro-
cesses, as has been demonstrated in mouse skin, needs additional
study in human skin.
LAMELLARGRANULE ASSEMBLY
An unanswered question in the ¢eld of epidermal barrier
formation is how keratinocyte LG assembly is orchestrated. Con-
taining both lipid membranes and acid hydrolases destined for
extrusion into the extracellular environment, the LG is some-
thing of a cross between a secretory granule and a lysosome.
A large body of evidence now supports the concept that LG
Figure 8. Schematic diagram of the epidermis, including the trans-
formations of lipid structures that accompany epidermal di¡eren-
tiation. Keratin ¢laments are omitted. Not to scale.
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originate from the Golgi apparatus and the very active and ra-
pidly advancing ¢eld of Golgi research is ripe for application
to keratinocyte biology. Of particular interest is recent work on
the trans-Golgi network, which is the highly tubulated sorting
and delivery portion of the Golgi apparatus. It is now thought
that Golgi to plasma membrane transport is mediated by
pleiomorphic tubulovesicular structures (sometimes referred to
as ‘‘post-Golgi carriers’’) that are formed by maturation of the
trans-Golgi compartment, rather than by vesicles (Hirschberg
et al, 1998; Mironov et al, 1998). In this paradigm, secretory orga-
nelles are the remnants of Golgi cisternae that have already ex-
ported all of the components not destined for secretion; thus
they are formed by terminal maturation of trans-Golgi network
cisternae.
Careful examination of high magni¢cation electron
microscopy images of epidermis clearly shows that LG do not
constitute a uniform vesicular population. There are numerous
highly irregular shapes, including ovals, dumbbells, and elon-
gated tubular structures ¢lled with the characteristic stacked
lamellae. These images are consistent with sections through a
tubular network (Madison and Howard, 1996; Elias et al, 1998;
Madison et al, 1998) suggesting that keratinocyte lamellar ‘‘gran-
ules’’ are trans-Golgi network structures and that the secretion of
their contents may be an excellent example of the current Golgi
paradigm. Further studies are needed to determine the validity of
this paradigm and/or whether the speci¢c mechanisms may be
unique to keratinizing epithelia. Norlen (2001a) has recently pro-
posed a ‘‘membrane folding model’’ of barrier lipid delivery that
does not require membrane tra⁄cking or fusion as classically
described.
Even if we accept the Golgi origin of lamellar ‘‘granules’’, how
all of the enzymes involved in barrier lipid synthesis are regu-
lated, how the internal membranes are formed, how lysosomal
enzymes are incorporated into the membrane structure, what sti-
mulates fusion (if classic membrane fusion does occur) with the
keratinocyte plasma membrane, and how the whole process is co-
ordinated with the many other events occurring during terminal
epidermal di¡erentiation are questions that remain to be an-
swered. Clearly, disruptions in any of these processes could have
a signi¢cant e¡ect on SC barrier function.
FLAKY SKIN
Flaky skin, often called ‘‘dry’’ skin, is a cutaneous reaction pattern
re£ecting abnormal desquamation of diverse etiologies. Corneo-
cytes are normally shed in small enough groups that they are not
visible on the skin surface; when this process is disturbed in any
way, corneocytes collect in visible clumps (scales) that produce a
rough texture and appearance.
The importance of SC water content to ‘‘normal’’ non£aky skin
appearance has long been known, with healthy tissue containing
greater than 10% water (Blank, 1952, 1953). Both water soluble in-
tracorneocyte substances (collectively referred to as natural moist-
urizing factor (NMF)) (reviewed in Harding et al, 2000) and the
intercellular lipid membranes (Imokawa et al, 1991) contribute to
the water binding properties of the SC and the barrier properties
of the intercellular membranes maintain hydration by limiting
water loss from the tissue. NMF consists of a mixture of amino
acids and their derivatives (pyrrolidone carboxylic acid, urocanic
acid), lactic acid, urea, and sugars that is highly hygroscopic and
acts as an endogenous humectant. The amino acid portion of
NMF derives from proteolysis of ¢laggrin (from keratohyalin
granules) in the mid to outer SC (Harding et al, 2000). One of
the critical functions of water in the SC is participating in the
many hydrolytic enzymatic processes required for normal des-
quamation (discussed above) and for the generation of NMF.
Knowing this, we can predict that any endogenous defect (pri-
mary or secondary) or exogenous insult that decreases SC NMF
content, alters the composition or physical properties of the inter-
cellular lipids, or disrupts epidermal di¡erentiation may lead to
improper desquamation and clinical scaling. This is a simpli¢ca-
tion of a very complex situation, but helps in thinking about
some mechanisms that can lead to ‘‘£aky’’ skin. Examples include
ichthyosis vulgaris, where there is a profound de¢ciency in ¢lag-
grin (Sybert et al, 1985) (and thus NMF), aged skin where lipid
synthesis (particularly cholesterol) is decreased leading to poor
barrier repair after insults (Ghadially et al, 1995, 1996a), and so-
called ‘‘winter xerosis’’ where low environmental humidity de-
creases SC water content.Whether ‘‘£aky skin’’ will have impaired
barrier function depends on the underlying pathophysiology as
well as the e¡ect of any compensatory response. Patients with la-
mellar ichthyosis due to transglutaminase 1 de¢ciency have ab-
normal corni¢ed envelope structure and dramatically scaly skin.
Their impaired barrier function has been reported to be due to
defects in the composition and organization of the SC lipid la-
mellae (Lavrijsen et al, 1995; Pilgram et al, 2001; Elias et al, 2002)
directly related to the underlying disturbance in the corni¢ed en-
velope (Elias et al, 2002). In epidermolytic hyperkeratosis, which
is caused by genetic defects in the suprabasal keratins 1 and 10,
keratinocytes are fragile and patients have both blistering and se-
vere scaling. The barrier defect, however, has been shown to be
due to abnormal LG secretion and the resulting decrease in SC
lipid lamellae (Schmuth et al, 2001). In many in£ammatory skin
diseases where overall epidermal di¡erentiation is disturbed, there
are likely secondary e¡ects on corneocyte structure and NMF
generation as well as on the composition and function of the in-
tercellular lipids that ultimately result in scaling. It should be
noted here that sebaceous gland secretions (sebum) are unlikely
to play a signi¢cant part in epidermal moisturization in humans;
prepubertal children, who have essentially no sebum production,
have enviable skin qualities and certainly no particular di⁄culties
with xerosis.
SKIN DISEASES WITH ABNORMALITIES IN BARRIER
FUNCTION AND IN LIPID METABOLISM
There are several genetic skin diseases with known defects in li-
pid metabolism that have scaly or ichthyotic skin as part of the
clinical picture (reviewed in Williams and Elias, 2000). RXLI,
discussed above, was the ¢rst of these diseases to be described.
Others include Sj˛gren^Larsson syndrome (defect in fatty alde-
hyde dehydrogenase; De Laurenzi et al, 1996), Refsum’s disease
(defect in phytanoyl-coenzyme A hydroxylase; Jansen et al, 1997),
and X-linked dominant Conradi^Hunermann as well as CHILD
syndrome (Congenital Hemidysplasia with Ichthyosiform ery-
throderma and Limb Defects; defects in 3b -hydroxysteroid-D 8,
D7-isomerase, an enzyme in the sterol biosynthetic pathway;
Braverman et al, 1999; Grange et al, 2000). CHILD syndrome can
also be caused by mutations in the gene encoding 3b -hydroxys-
teroid dehydrogenase (Konig et al, 2000). Very recently, Chanar-
in^Dorfman syndrome (neutral lipid storage disease with
ichthyosis), which is characterized by nonbullous congenital
ichthyosiform erythroderma, was found to be caused by muta-
tions in a gene (CGI-58) that encodes a new protein of unknown
function in the esterase/lipase/thioesterase family (Lefevre et al,
2001). Mutations in lipoxygenase-3 (ALOXE3) and 12R-lipoxy-
genase (ALOX12B) have now been reported in nonbullous con-
genital ichthyosiform erythroderma linked to chromosome
17p13.1 (Jobard et al, 2002). Although the substrates and products
of these lipoxygenases are not yet known, further investigation
should shed considerable light on the functional role of lipoxy-
genase pathways in epidermal di¡erentiation. For the majority of
these diseases, even when the defect is known, the precise me-
chanism by which SC structure and function are altered has not
been determined. Harlequin ichthyosis is characterized by an ab-
sence of LG and SC lipid lamellae (Milner et al, 1992). Some
subtypes of congenital ichthyosiform erythroderma show
abnormalities in lipid structures (Arnold et al, 1988) and there are
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some cases that share the microscopic ¢ndings reported for harle-
quin ichthyosis (Virolainen et al, 2001), but the underlying defects
in these genetic diseases remain unknown.
Netherton syndrome and Papillon^Lefevre syndrome are
caused by defects in proteolysis: mutations in SPINK5, a serine
protease inhibitor (Chavanas et al, 2000), and cathepsin C (Hart
et al, 1999), respectively. Abnormalities in SC lipid structure have
been described in Netherton syndrome (Fartasch et al, 1999), but
how SPINK5 defects result in these alterations is not known. A
recent paper reported that SC hydrolytic activity is increased in
Netherton syndrome and the authors suggest that SPINK5 is ne-
cessary to regulate the enzymes involved in desquamation (Ko-
matsu et al, 2002). Type 2 Gaucher disease, with severe defects in
b-glucocerebrosidase, discussed above, results in failure to meta-
bolize LG glucosylceramides to ceramides. The recent ¢nding of
delayed barrier repair in Niemann^Pick disease (acid sphingo-
myelinase de¢ciency) (Schmuth et al, 2000) suggests these patients
might be more susceptible to exogenous barrier insults. Many ge-
netic skin diseases with defects in a variety of epidermal protein
structures, as discussed above for lamellar ichthyosis and epider-
molytic hyperkeratosis, have associated changes in SC lipid struc-
ture and function and these are currently being investigated.
Of the in£ammatory skin diseases, atopic dermatitis and psor-
iasis have been the most studied with respect to epidermal barrier
function and SC lipid alterations. A decrease in ceramides has
been the most consistent ¢nding in atopic dermatitis and this
has been suggested to result from increased sphingomyelin dea-
cylase activity (Hara et al, 2000). Macheleidt et al (2002) have re-
cently demonstrated decreased free very long chain fatty acids
and lipid envelope o-hydroxyceramides in atopic skin as well as
decreased very long chain fatty acid, ceramide, and glucosylcera-
mide synthesis by atopic epidermis in vitro. Although the mechan-
isms underlying these changes are not known, the ¢ndings o¡er
an explanation for the decreased barrier function of atopic skin.
In addition, gene polymorphisms in SPINK5, the gene mutated
in Netherton syndrome (which has atopy as part of the clinical
picture), have been found to show signi¢cant association with
common atopic disease, including atopic dermatitis (Walley et al,
2001). Combined with the recent demonstration that mice over-
expressing SC chymotryptic enzyme develop a chronic itchy der-
matitis (Hansson et al, 2002), this suggests tantalizing links
between excess protease activity, barrier function, epidermal dif-
ferentiation, and in£ammation. In psoriasis, alterations in cera-
mide content have been demonstrated (Motta et al, 1994) and
abnormal lipid structures reported (Ghadially et al, 1996b). More
work is needed to determine whether these changes are primary
or secondary and/or are speci¢c for the disease.
NEONATAL SKIN
Current dogma holds that the SC is not functionally mature until
32 to 34wk estimated gestational age and that the skin of prema-
ture infants develops competent barrier function within 2 to 4wk
of birth regardless of gestational age. A recent longitudinal study
in premature infants suggests that the barrier may be mature at
about 30wk, but that for neonates younger than 25wk estimated
gestational age, postnatal barrier maturation may take as long as 5
to 7wk (Kali et al, 1998). The high TEWL from premature infant
skin can lead to multiple complications and a mainstay of therapy
is to prevent this loss by maintaining a humidi¢ed environment
or using petrolatum-based topical preparations until a competent
barrier develops (Siegfried, 1998). In the future, this problem may
be approached by stimulating the normal development of barrier
function (either in utero, if possible, or postnatally) and/or provid-
ing a more physiologic temporary arti¢cial barrier. Studies of fe-
tal rat barrier development suggest that acceleration of this
process is possible (Williams et al, 1998; Hanley et al, 1999), but this
has not yet been shown in humans. In fact, a recent study of bar-
rier maturation in preterm infants showed no stimulation by the
administration of antenatal steroids and no di¡erence between
the sexes (Jain et al, 2000), although steroids stimulate, and testos-
terone inhibits, barrier development in the rat model. If topically
applied physiologic lipids must enter LG and be extruded to im-
prove barrier function (see below), this approach may not work
in premature skin where LG assembly and secretion might be
relatively undeveloped. If a mix of appropriate lipids could be
prepared such that they would function as they do in vivo, how-
ever, repeated topical application should provide a physiologic
barrier until normal epidermal maturation occurs. Any improve-
ment in the current management of these fragile infants would be
a valuable clinical contribution from basic work on epidermal
barrier development and function.
‘‘MOISTURIZERS’’AND BARRIERCREAMS
The use of topically applied materials to improve the appearance,
function, and ‘‘feel’’ of skin is as old as human life. Our knowl-
edge about the mechanisms by which all of these agents work
continues to evolve along with our understanding of SC struc-
ture and function and at present is incomplete. As discussed
above, £aky ‘‘dry’’ skin is a heterogeneous condition with varied
pathogenetic mechanisms that may or may not be associated with
altered barrier function. It follows that controlled studies in
homogeneous populations of patients would be necessary to es-
tablish the e⁄cacy of an agent or product for a given condition.
The term moisturizer implies that the substance applied adds
water and/or retains water in the SC. This is true for many of
the products in use today, although the mechanism by which this
is accomplished may vary. In addition, ‘‘moisturizing’’ substances
are known to have a variety of less well de¢ned e¡ects on SC
function separate from their e¡ects on water content. Urea, pro-
pylene glycol, glycerin, and hydroxy acids (especially lactic acid)
are humectants (water holding) and are used in many moisturiz-
ing formulations; however, they all also function as exfoliants,
i.e., they promote desquamation. Although some of these sub-
stances are referred to as ‘‘keratolytics’’, true protein denaturation
only occurs at high concentrations that are not used in moisturiz-
ing formulations.Whether the e¡ect of these agents on desqua-
mation is due solely to the increased water content or whether
they have other e¡ects on the desquamation process has not been
completely worked out.
Another mechanism for moisturizing skin is to provide an
exogenous barrier to water loss (TEWL) so that more water is
retained in the SC, a ‘‘barrier cream’’. This is the mechanism by
which petrolatum works, but rather than simply forming a ¢lm
on the skin surface, it has been shown in hairless mice that petro-
latum penetrates into the intercellular spaces of the SC to provide
this function (Ghadially et al, 1992). Studies in hairless mice have
also shown that certain combinations of SC lipids in optimal ra-
tios can accelerate restoration of barrier function following tape
stripping or acetone abrogation of the barrier (Mao-Quiang et al,
1995, 1996). Importantly, certain lipid mixes actually inhibited re-
storation of barrier function, which has implications for the de-
sign of topical products. There are relatively few studies on
human skin of products containing the appropriate mix of SC
lipids, with varying results (Loden and Barany, 2000; Chamlin
et al, 2002). Additional well-controlled trials in de¢ned human
populations are needed to determine if mixtures of SC lipids are
superior to other formulations.
In mouse skin, it is argued that topically applied lipids can
permeate to the granular layer where they become part of LG
membranes and are then extruded into the intercellular space to
form the intercellular lamellae (Mao-Quiang et al, 1995). These
¢ndings, however, need to be con¢rmed in additional animal
models and extended to human skin. It has also been shown that
a mixture of SC lipids applied to lipid-extracted SC sheets can
restore barrier function (Onken and Moyer, 1963; Imokawa et al,
1991) and reform intercellular lamellae (Imokawa et al, 1991) and
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that mixtures of SC lipids can form bilayer structures in vitro
(Kuempel et al, 1998).This suggests that in situ formation of barrier
lipid membranes by topically applied lipids is another possible
mechanism of barrier restoration. Ultimately, the goal is to be
able to tailor topical products to the needs of patients based on
speci¢c knowledge of their underlying epidermal defects and a
more complete understanding of how these products work at
the molecular level.
OTHERCOMPONENTS OF EPIDERMAL BARRIER
FUNCTION
Although tight junctions have been sporadically observed in epi-
dermis for many years, and tight junction proteins are expressed
in epidermis (Morita et al, 1998), it was not until the recent devel-
opment of a claudin-1 knockout mouse (Furuse et al, 2002) that the
functional role of epidermal tight junctions was examined. The
neonatal knockout mice showed wrinkled skin with markedly in-
creased TEWL and died within 1d of birth. Expression of loricrin,
involucrin, and transglutaminase were normal, and lamellar lipid
structures in the LG extrusion zone and the SC appeared normal.
Whereas it is not surprising, given the importance of the epidermal
barrier, that there should be more than one mechanism contribut-
ing to barrier function, it is interesting that neither system is able
to compensate for defects in the other. As claudin-1-de¢cient SC
appears di¡erent on histology and electron microscopy (more
compact and without a ‘‘basketweave’’artifact), it will be important
to conduct more detailed studies of the lipid composition and
structure in these mice to determine whether or not lipid altera-
tions contribute to the diminished barrier function.
CHALLENGES
Relatively few mechanistic studies of barrier repair or moisturizer
e¡ects on human skin have been performed. Short-term acetone
treatment, a commonly used ‘‘barrier disrupter’’ in many models,
does not extract signi¢cant amounts of barrier lipids from normal
human skin (Onken and Moyer, 1963; Adams et al, 1993) and the
mechanism of its e¡ect on barrier function has not been su⁄-
ciently investigated. A variety of solvents, including acetone, may
give spurious TEWL readings (Morrison, 1992; Adams et al, 1993)
suggesting that solvent-induced barrier dysfunction may be a less
desirable model. Other models of barrier disruption, both experi-
mentally induced and natural (due to disease, genetic manipula-
tion, or environmental conditions) are available, but there
remains a need for more sophisticated and controlled methods to
disrupt barrier function. Because TEWL data are a¡ected by a
number of variables, including varying by up to about 20% based
on circadian rhythms alone (Le Fur et al, 2001), measurements ob-
tained after experimental manipulation of the skin require very
careful interpretation (McCallion and Li Wan Po, 1995; Orth and
Appa, 2000) with attention to physiologic and clinical versus statis-
tical signi¢cance. In fact, recent studies by Chilcott et al (2002)
showed no correlation between measured TEWL and skin barrier
function. Although these rather startling ¢ndings need to be du-
plicated by other investigators and in other models, the authors
correctly conclude that further work needs to be done on the in-
terpretation of TEWL. It is best for studies of SC function to
measure multiple parameters including clinical appearance,
TEWL, SC water content, permeability to exogenous substances,
lipid content and composition (and ideally synthesis), and mor-
phology. Although the use of ruthenium tetroxide post¢xation
in electron microscopy allows visualization of the SC lipid lamel-
lae and is now widely used to assess changes in lamellar structure
under a variety of conditions, this technique is far from optimal
for overall preservation of tissue architecture and is known to re-
sult in numerous artifacts (Swartzendruber et al, 1995). For this rea-
son, establishing true di¡erences between normal versus abnormal
tissue or treated versus untreated tissue using this technique can be
problematic. For both osmium- and ruthenium-¢xed samples, it
is best to have the microscopist blinded to the status of the tissues
if possible, multiple samples and sections must be examined, and
nondramatic ¢ndings of di¡erence quantitated wherever possible.
FUTURE DIRECTIONS
Studies of epidermal di¡erentiation in keratinocyte culture mod-
els and in fetal development models will continue to improve our
understanding of the mechanisms underlying SC barrier forma-
tion and how they are regulated. Biophysical studies of SC lipids
will delineate the molecular basis for their barrier properties. So-
phisticated cell-free in vitro systems will be developed to study la-
mellar ‘‘granule’’ assembly and the membrane dynamics involved
in the formation of SC lamellae. Transgenic and knockout mice
with unexpected barrier defects will be helpful in delineating
new regulatory pathways in barrier formation. The development
of rodent models with defects in speci¢c aspects of barrier lipid
metabolism will improve our understanding of barrier disrup-
tion, as we have already seen with b-glucocerebrosidase-de¢cient
mice and acid sphingomyelinase-de¢cient mice. Careful interpre-
tation and clinical application of all of these ¢ndings will greatly
improve the speci¢city and e⁄cacy of treatments for human skin
with abnormal SC structure and function.
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